Immunotherapy in High-risk Ductal Carcinoma in Situ (DCIS)
Clinical trial NCT02872025 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02872025
- Sponsor
- Laura Esserman
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-12
- Primary completion
- 2026-03-31
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.